Antibiotic resistance (AMR) is a growing global health threat, as bacteria develop resistance to antibiotics, making infections harder to treat. This review discusses the development of extensively drug-resistant (XDR) and multidrug-resistant (MDR) bacterial strains, with a focus on case studies from Saudi Arabia and other countries. The study highlights the genetic variations in resistance mechanisms and the increasing risk posed by superbugs. It also emphasizes the need for national action plans, stewardship programs, and research into new antibiotics to combat AMR. AMR is caused by bacteria modifying themselves to survive and resist antibiotics. It can occur through intrinsic resistance, acquired resistance, or adaptive resistance. The mechanisms of resistance include the inactivation of antibiotics by enzymes, efflux pump systems, and target site modifications. Efflux pumps expel antibiotics from bacterial cells, while target modifications prevent drugs from binding to their intended targets. Drug metabolism involves enzymes that inactivate antibiotics, making them ineffective. XDR strains are resistant to all but one or two antimicrobials, while MDR strains are resistant to at least three classes of antibiotics. The rise of these strains is attributed to the overuse and misuse of antibiotics, poor regulations, and the lack of new antibiotics. The study also highlights the role of agricultural and veterinary use of antibiotics in the spread of resistance. The review presents case studies from various countries, including Taiwan, Pakistan, China, India, Egypt, and Saudi Arabia, illustrating the prevalence and impact of MDR and XDR strains. These cases highlight the challenges in treating infections caused by these resistant bacteria and the need for improved antibiotic stewardship and research into new treatments. The global implications of AMR are significant, with estimates suggesting that AMR could cost the global economy up to $100 trillion by 2050. The review underscores the urgent need for international cooperation, research into new antibiotics, and the implementation of effective strategies to combat AMR. The study concludes that immediate action is necessary to address the growing threat of antibiotic resistance and ensure the continued effectiveness of antibiotics in treating bacterial infections.Antibiotic resistance (AMR) is a growing global health threat, as bacteria develop resistance to antibiotics, making infections harder to treat. This review discusses the development of extensively drug-resistant (XDR) and multidrug-resistant (MDR) bacterial strains, with a focus on case studies from Saudi Arabia and other countries. The study highlights the genetic variations in resistance mechanisms and the increasing risk posed by superbugs. It also emphasizes the need for national action plans, stewardship programs, and research into new antibiotics to combat AMR. AMR is caused by bacteria modifying themselves to survive and resist antibiotics. It can occur through intrinsic resistance, acquired resistance, or adaptive resistance. The mechanisms of resistance include the inactivation of antibiotics by enzymes, efflux pump systems, and target site modifications. Efflux pumps expel antibiotics from bacterial cells, while target modifications prevent drugs from binding to their intended targets. Drug metabolism involves enzymes that inactivate antibiotics, making them ineffective. XDR strains are resistant to all but one or two antimicrobials, while MDR strains are resistant to at least three classes of antibiotics. The rise of these strains is attributed to the overuse and misuse of antibiotics, poor regulations, and the lack of new antibiotics. The study also highlights the role of agricultural and veterinary use of antibiotics in the spread of resistance. The review presents case studies from various countries, including Taiwan, Pakistan, China, India, Egypt, and Saudi Arabia, illustrating the prevalence and impact of MDR and XDR strains. These cases highlight the challenges in treating infections caused by these resistant bacteria and the need for improved antibiotic stewardship and research into new treatments. The global implications of AMR are significant, with estimates suggesting that AMR could cost the global economy up to $100 trillion by 2050. The review underscores the urgent need for international cooperation, research into new antibiotics, and the implementation of effective strategies to combat AMR. The study concludes that immediate action is necessary to address the growing threat of antibiotic resistance and ensure the continued effectiveness of antibiotics in treating bacterial infections.